Karyopharm Therapeutics
company
Funding Round
Post-IPO Equity
Money Raised
$ 165M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| Avidity Partners | - | Yes | - | Detail |
| Adage Capital Management | - | - | - | Detail |
| Armistice Capital | - | - | - | Detail |
| HealthCor Partners | - | - | - | Detail |
| Heights Capital Management | - | - | - | Detail |
| Marshall Wace | - | - | - | Detail |
| Rubric Capital Management | - | - | - | Detail |
| SilverArc Capital | - | - | - | Detail |
| Surveyor Capital | - | - | - | Detail |
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Jun 30, 2014 | Post-IPO Equity | $ 111M | Detail | |
| Mar 6, 2020 | Post-IPO Equity | $ 172.50M | Detail | |
| Jul 31, 2013 | Series B | $ 19M | Delphi Ventures,Foresite Capital,etc. | Detail |
| May 20, 2013 | Series B | $ 48.20M | Delphi Ventures | Detail |
| Nov 3, 2010 | Series A | $ 20M | Detail | |
| Jan 6, 2011 | Grant | $ 1M | Multiple Myeloma Research Foundation | Detail |
| Nov 2, 2011 | Series A | $ 10M | Chione | Detail |
| Nov 6, 2013 | IPO | $ 108.80M | Detail |
